Provenienza dei contatti di primo grado di Nathalie Thomas-Pujol
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
4
| Public Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nathalie Thomas-Pujol tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Director of Finance/CFO | |
| Aventis, Inc. | Comptroller/Controller/Auditor | ||
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
| THERADIAG | Medical Specialties | Chief Executive Officer Chief Executive Officer | |
| EM Lyon Business School | College/University | Undergraduate Degree | |
PricewaterhouseCoopers Audit SA
 PricewaterhouseCoopers Audit SA Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers Audit SA provides accounting, auditing and consulting services. The company was founded on February 10, 1967 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Founder Private Equity Analyst | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| Drugabuse Sciences, Inc. | Founder | ||
| Sangstat Pharmaceuticals Corp. | Founder | ||
| CARMAT | Medical Specialties | Founder Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Founder | |
| THERACLION | Medical Specialties | Director/Board Member | |
Wittycell SAS
 Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Pharmaceuticals: Major | Founder | |
| VEXIM | Medical Specialties | Founder | |
| Holding Incubatrice Biotechnologie | Investment Managers | Chief Executive Officer | |
| Conseil Stratégique pour l'Innovation | Chairman | ||
| Strategic Council on Business Attractiveness | Corporate Officer/Principal | ||
Prestizia SASU
 Prestizia SASU Miscellaneous Commercial ServicesCommercial Services Part of Biosynex SA, Prestizia SASU is a French company that provides biotechnology research and development services. The company is based in Paris, France. Odile Prigneau has been the CEO of the company since 2013. Prestizia was acquired by Theradiag SA, a subsidiary of Biosynex SA from Truffle Capital SAS on June 27, 2012. | Miscellaneous Commercial Services | Chairman | |
| CARBIOS | Miscellaneous Commercial Services | Founder | |
Kardiozis SAS
 Kardiozis SAS Medical SpecialtiesHealth Technology Kardiozis SAS engages in radio diagnostic and radiotherapy activities. It also develops aortic stent. The company was founded on March 15, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Epygon SASU
 Epygon SASU Medical SpecialtiesHealth Technology Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Bioxodes SA
 Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| Jax Genomic Medicine | Corporate Officer/Principal | ||
| AFFLUENT MEDICAL | Medical Specialties | Founder Chief Executive Officer | |
Nanosive SASU
 Nanosive SASU Miscellaneous Commercial ServicesCommercial Services Nanosive SASU engages in research and development in other physical and natural sciences. The company was founded by Philippe Pouletty on December 20, 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Founder | |
| Artedrone SAS | Director/Board Member | ||
| Shanghai Myopowers Medical Technology Co. Ltd. | Director/Board Member | ||
| Myopowers Medical Technolgies SA, (Zweigniederlassung Basel) | Director/Board Member | ||
| Bmd SA | Chairman | ||
| Holistick Medical Sasu | Director/Board Member | ||
| Skinosive Sasu | Chairman | ||
| Pk Med SAS | Chairman | ||
| Caranx Medical SAS | Founder | ||
| Bariatek Medical SAS | Director/Board Member | ||
| Spikimm SAS | Chairman | ||
Plasmaprime SAS
 Plasmaprime SAS Medical/Nursing ServicesHealth Services Plasmaprime SAS provides plasma derived drugs collected from blood transfusion centers. The company was founded by Heriberto Sieler and Philippe Pouletty on January 23, 2009 and is headquartered in Evry, France. | Medical/Nursing Services | Founder | |
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Francia | 39 |
| Stati Uniti | 6 |
| Belgio | 3 |
| Germania | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 23 |
| Commercial Services | 7 |
| Finance | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 44 |
| Founder | 21 |
| Chairman | 19 |
| Corporate Officer/Principal | 8 |
| Chief Executive Officer | 5 |
Contatti più connessi
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| Michel Finance | 15 |
| Thérèse Croughs | 6 |
| Jacques Banchereau | 4 |
- Borsa valori
- Insiders
- Nathalie Thomas-Pujol
- Connessioni Società
